A new test may spot which women need pain care before endometriosis surgery

NCT ID NCT06997809

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This trial tests whether screening women with endometriosis for pain complications before surgery, and offering specialized pain care to those who need it, improves their quality of life a year after the operation. Researchers will compare women who receive this extra pain management pathway with those who get standard surgical care alone. The study includes women aged 18 to 50 with confirmed endometriosis and pain that affects their daily life, who are scheduled for surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A care pathway that adds a specialized pain consultation before endometriosis surgery, with tailored pain treatment if screening tests are positive.
What this could lead to
If it works, this could show that screening for pain complications before surgery and treating them improves quality of life after endometriosis surgery.
What could go wrong
The trial is relatively small and early, and the benefit may not be clear. The added consultation could delay surgery or not help all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 187 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Maternal age from 18 up to 50 years old (50 non included). * Women affiliated to social coverage insurance * Women who understand French * Women who signed the written consent * Women with impaired quality of life (pain) linked to endometriosis * Women with formal radiological signs of endometriosis (MRI lesions more than 5 mm or endometrioma more than 20 mm on radiological examinations). * Surgical indication for resection of lesions by laparoscopy or robotic surgery for management of pain or impairment of quality of life * Patients requiring complete conservative or radical resections of all lesions * Indication of surgery validated within dedicated meeting for endometriosis. * Purpose of pain associated or not with infertility * Date of surgery fixed with sufficient time for algological treatment. Maximum delay of 4 months between randomization and surgery Exclusion criteria: * Women undergoing surgery for the purpose of infertility * Patient with previous surgery for removal of deep lesions of endometriosis or endometriotic cysts (history of exploratory laparoscopy accepted) * Patient with suspicious lesions on MRI or specialized ultrasound. * A patient who needs to be treated for another uterine pathology at the same time. * Pregnant women * Patient with a desire for pregnancy immediately and/or within one year after surgery * Women who refuse clinical examination (some algological tests couldn't be performed without clinical examination) * Patient who has already received algological treatment or who should receive it before surgery * Patient with previous other psychiatric disorders (depressive symptoms treated) * Women without rights

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis, pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bordeaux University Hospital

    NOT_YET_RECRUITING

    Bordeaux, France, 33000, France

  • IFEMENDO

    NOT_YET_RECRUITING

    Bordeaux, France, 33000, France

  • Limoges University hospital

    RECRUITING

    Limoges, France, 87042, France

  • Mutual Clinic La Sagesse

    NOT_YET_RECRUITING

    Rennes, France, 33043, France

  • Poissy-St-Germain Intercommunal hospital center

    NOT_YET_RECRUITING

    Poissy, France, 78303, France

  • Poitiers University Hospital

    NOT_YET_RECRUITING

    Poitiers, France, 86000, France

  • Saint-Vincent-de-Paul Hospital

    NOT_YET_RECRUITING

    Lille, France, 59000, France

  • South Hospital Rennes University Hospital

    NOT_YET_RECRUITING

    Rennes, France, 35203, France

  • Versailles Hospital

    NOT_YET_RECRUITING

    Le Chesnay, France, 78150, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.